KA
CVS icon

Klingman & Associates’s CVS Health CVS Stock Holding History

Klingman & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Sell
2,331
-1,345
-37% -$120K 0.01% 308
2026
Q1 		$264K Sell
3,676
-386
-10% -$29.7K 0.01% 279
2025
Q4 		$322K Buy
4,062
+615
+18% +$48.5K 0.02% 244
2025
Q3 		$260K Buy
3,447
+266
+8% +$18.2K 0.01% 281
2025
Q2 		$219K Sell
3,181
-130
-4% -$8.53K 0.01% 286
2025
Q1 		$224K Buy
+3,311
New +$198K 0.01% 248
2024
Q4 		– Sell
-3,798
Closed -$239K – 259
2024
Q3 		$239K Sell
3,798
-1,214
-24% -$70.8K 0.01% 247
2024
Q2 		$296K Sell
5,012
-246
-5% -$15.4K 0.02% 195
2024
Q1 		$419K Buy
5,258
+24
+0.5% +$1.83K 0.03% 161
2023
Q4 		$413K Buy
5,234
+93
+2% +$6.62K 0.03% 152
2023
Q3 		$359K Buy
5,141
+1,903
+59% +$135K 0.03% 159
2023
Q2 		$224K Buy
3,238
+282
+10% +$20.1K 0.02% 200
2023
Q1 		$220K Sell
2,956
-415
-12% -$34.8K 0.02% 186
2022
Q4 		$314K Buy
3,371
+334
+11% +$32.2K 0.03% 154
2022
Q3 		$290K Buy
3,037
+78
+3% +$7.72K 0.03% 151
2022
Q2 		$274K Sell
2,959
-4,013
-58% -$392K 0.03% 156
2022
Q1 		$705K Buy
+6,972
New +$732K 0.06% 94
2016
Q4 		– Sell
-1,625
Closed -$145K – 148
2016
Q3 		$145K Buy
1,625
+350
+27% +$33K 0.04% 110
2016
Q2 		$122K Hold
1,275
– – 0.04% 120
2016
Q1 		$132K Hold
1,275
– – 0.05% 116
2015
Q4 		$125K Hold
1,275
– – 0.05% 139
2015
Q3 		$123K Hold
1,275
– – 0.05% 140
2015
Q2 		$134K Sell
1,275
-200
-14% -$20.4K 0.05% 105
2015
Q1 		$152K Hold
1,475
– – 0.06% 93
2014
Q4 		$142K Buy
+1,475
New +$130K 0.06% 100

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Klingman & Associates's CVS Position: Q2 2026 in Review

Klingman & Associates reduced its CVS Health (CVS) stake by 37% in Q2 2026, selling an estimated $120K and leaving 2,331 shares worth $241K. The position accounts for 0.01% of the portfolio, ranked #308.

Klingman & Associates first reported a position in CVS in Q4 2014 and has held it in 25 quarters since. The position peaked at $705K in Q1 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Klingman & Associates held 2,331 shares of CVS Health worth $241K as of Q2 2026.
  • Klingman & Associates sold 1,345 CVS Health shares in Q2 2026, an estimated $120K.
  • CVS Health made up 0.01% of Klingman & Associates's portfolio in Q2 2026, its #308 holding.
  • Klingman & Associates first reported a position in CVS Health in Q4 2014 and has held it in 25 quarters since.
  • Klingman & Associates's CVS Health position peaked at $705K in Q1 2022.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Klingman & Associates's 13F filing for Q2 2026, filed 29 Jul 2026.